India-based Suven Life Sciences has announced the dosing of the first subjects in its Phase I clinical trial of SUVN-I6107 to ...

Suven Life Sciences Limited (Formerly known as Suven ... ANDA with the USFDA authorities for Malathion lotion, a head-lice product with sales potential estimated at US$35 million.

Suven Life Sciences Ltd. is a Public Limited Listed ... medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 11.84 Cr. and Equity Capital is Rs.

Suven Life Sciences surged 9.51% to Rs 138.70 after the firm dosed first subjects in a Phase-1 clinical trial of SUVN-I6107 being conducted in USA under FDA acceptance of investigational new drug (IND ...

Suven Life Sciences has reported a sales standalone turnover of Rs 108.67 crore and a net profit of Rs 29.77 crore for the quarter ended Jun '13 Suven Life Scie standalone Mar '13 sales at Rs 74. ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.

During the year under review, Company continued to advance its innovation on discovering and developing novel pharmaceutical products ... growth of the Company. Suven Life Employee Stock Option ...

Suven Life Sciences Ltd share price was up by 0.00% from the previous closing price of ₹127.92. Who are peers of Suven Life Sciences Ltd? The peers of Suven Life Sciences Ltd are Max Healthcare ...

Learn about Suven Life Sciences Ltd. in Hyderabad, Telangana.Find comprehensive contact details, including phone numbers and email addresses, and get directions to the location. If you own or are ...